Anbio Biotechnology Class A Ordinary Shares

NasdaqGM:NNNN

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

Germany

Market Cap

USD 2.10 B

Share Price

USD 46.60

Avg Daily Volume

89,745

Change (1 day)

-2.41%

Change (1 year)

Change (YTD)

500.52%

Anbio Biotechnology Class A Ordinary Shares Accounts Payable for the year ending July 17, 2025: N/A

Anbio Biotechnology Class A Ordinary Shares Accounts Payable is NA for the year ending July 17, 2025. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Chugai Pharmaceutical Co., Ltd.

USD 46.49

4519.T

+0.50 1.10%

MERCK Kommanditgesellschaft auf Aktien

USD 128.56

MRK.DE

+0.95 0.75%

Agilent Technologies, Inc.

USD 113.43

+0.49 0.43%

Qiagen N.V.

USD 48.30

QGEN

+0.85 1.79%

Aurobindo Pharma Limited

USD 13.47

AUROPHARMA.NS

+0.05 0.35%

Repligen Corporation

USD 119.75

RGEN

+1.65 1.40%

Bruker Corporation

USD 41.54

BRKR

-0.42 -1.00%

Yuhan Corporation

USD 92.42

000100.KS

+11.84 14.69%

Pharmaron Beijing Co., Ltd.

USD 2.31

3759.HK

+0.05 2.14%

Bachem Holding AG

USD 72.25

BANB.SW

+1.25 1.77%

Siegfried Holding AG

USD 113.80

SFZN.SW

+2.70 2.43%

Gan & Lee Pharmaceuticals.

USD 8.10

603087.SS

+0.12 1.45%

Cohance Lifesciences Limited

USD 12.53

COHANCE.NS

+0.14 1.17%

Metsera, Inc.

USD 43.73

MTSR

+0.75 1.75%

Bloomage BioTechnology Corporation Limited

USD 7.16

688363.SS

+0.03 0.37%

Syngene International Limited

USD 7.84

SYNGENE.NS

+0.07 0.90%

Jafron Biomedical Co.,Ltd.

USD 3.12

300529.SZ

+0.01 0.23%

Beijing Hotgen Biotech Co., Ltd.

USD 27.72

688068.SS

+0.86 3.19%

Anhui Anke Biotechnology (Group) Co., Ltd.

USD 1.33

300009.SZ

+0.03 2.12%

Changzhou Qianhong Biopharma CO.,LTD

USD 1.59

002550.SZ

+0.10 6.65%

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities